Stay updated on Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial
Sign up to get notified when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.

Latest updates to the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.4.3 appears in the Study Record Versions, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and older government-funding notices were removed. These are administrative updates to the page history and do not affect the study record content.SummaryDifference0.9%

- Check37 days agoChange DetectedA site-wide notice about government funding and NIH Clinical Center status was added, with a link to opm.gov. The history also shows Revision: v3.4.1 added and Revision: v3.4.0 removed.SummaryDifference0.9%

- Check44 days agoChange DetectedUI updates include a 'Show glossary' option and color-coded change highlights (green for additions, red for deletions) with a new revision note (v3.4.0). The older revision note (v3.3.4) and related labeling appear to be superseded.SummaryDifference1%

- Check58 days agoChange DetectedRecord History shows a new revision from v3.3.3 to v3.3.4, indicating a minor site version update rather than changes to trial content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry (v3.3.3) was added to the Record History, and the footer removed the HHS Vulnerability Disclosure and the earlier Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.